Physician

James P. Conley, M.D.

According to 2025 Medicare claims, James Conley, M.D. (NPI: 1639137086) practices nephrology in the Muskegon-Norton Shores, MI market, with the plurality of this provider's patient population coming from Muskegon, MI. This provider's primary affiliated billing organization is WEST MICHIGAN NEPHROLOGY PLLC (NPI: 1235143090; TIN: 382690980) and primary practice location at 49444-1849. Conley is affiliated with the Trinity Health Integrated Care (ACO ID: A3454) and West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Conley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 288 traditional Medicare patients, billed 499 HCPCS/CPT codes, and received $53,848 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 910 prescription claims across 285 beneficiaries totaling $131,087 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 71 claims. Open Payments data shows 3 records totaling $72. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $266,867 to $131,087. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $0 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	458	1,016	$61,713
2016	459	1,040	$66,260
2017	426	1,067	$91,544
2018	391	992	$95,324
2019	412	979	$88,994
2020	386	728	$73,426
2021	360	639	$67,297
2022	309	498	$53,498
2023	281	493	$58,101
2024	288	499	$53,848

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	335	1,554	$266,867
2016	338	1,580	$360,904
2017	317	1,392	$204,924
2018	309	1,038	$90,299
2019	267	931	$88,993
2020	238	664	$57,452
2021	252	854	$61,606
2022	295	888	$108,056
2023	292	973	$208,754
2024	285	910	$131,087

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	42	166	$14,833
2016	11	198	$18,049
2017	N/R	127	$8,380
2018	N/R	109	$9,150
2019	N/R	64	$2,103
2020	N/R	28	$1,703
2021	N/R	47	$1,493
2022	N/R	64	$1,456
2023	N/R	56	$935
2024	N/R	71	$2,129

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	76	103	$249
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	33	37	$125
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	21	21	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	49	146	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	129	143	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	67	2,730	$51,287
Lokelma	Sodium Zirconium Cyclosilicate	17	675	$11,872
Jardiance	Empagliflozin	14	480	$9,294
Sps	Sodium Polystyrene Sulfon/Sorb	26	514	$5,755
Sevelamer Carbonate	Sevelamer Carbonate	27	1,510	$4,459

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7515	Cyclosporine, oral, 25 mg	N	N/R	20	$943
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	20	$414
J7500	Azathioprine, oral, 50 mg	N	N/R	11	$397
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	20	$376

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$72	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James P. Conley, M.D.?

Tedicare shows public-source Medicare data for James P. Conley, M.D. (NPI 1639137086), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James P. Conley, M.D. have ACO affiliation data?

James P. Conley, M.D. is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454) and West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to James P. Conley, M.D.?

James P. Conley, M.D. is linked to WEST MICHIGAN NEPHROLOGY PLLC (billing NPI 1235143090) in the available physician profile data.

Does James P. Conley, M.D. have Open Payments data?

James P. Conley, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.